drugset / Trial / NCT01429675
Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers
RandomizedCrossoverOpen-label
Summary
The purpose of this study is compare the pharmacokinetic characteristics of DP-R206 (150mg Ibandronate / 24,000 IU Vitamin D3 complex tablet, qd) and Bonviva (150mg Ibandronate, qd) after oral administration in healthy adult volunteers.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibandronate | Other / unclassified | 150 mg | Oral |
Indications
No indication recorded.